mGPDH catalyzes the oxidation of G3P while reducing ubiquinone (CoQ 10 ) to ubiquinol (CoQ 10 H 2 ), thereby helping to sustain the mitochondrial CoQ 10 H 2 pool and suppress lipid peroxidation
Saxenda, the second to be approved, only achieved middling weight-management results for a large share of those who took it, and physicians were reticent to prescribe weight-loss medications after the disastrous effects of drugs such as fen-phen were revealed in the late 90s
For clinics, this is a prime opportunity to capture this market through more efficient and convenient non-surgical in-office solutions like Sofwave
Flatulence: Did we mention the gas
Available to the public in the form of dietary supplements for the past few decades, this molecule, discovered in 1899, was studied extensively in the 1990s, particularly in the fields of pulmonology, immunology and neurology (2)